Dynamic Advisor Solutions’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-877
Closed -$203K 936
2024
Q2
$203K Sell
877
-454
-34% -$98.7K 0.01% 876
2024
Q1
$287K Sell
1,331
-3,519
-73% -$824K 0.01% 776
2023
Q4
$1.25M Buy
4,850
+285
+6% +$70K 0.05% 363
2023
Q3
$1.17M Buy
4,565
+21
+0.5% +$5.62K 0.06% 315
2023
Q2
$1.29M Buy
4,544
+1,178
+35% +$351K 0.07% 287
2023
Q1
$936K Buy
+3,366
New +$931K 0.05% 332
2018
Q4
Sell
-948
Closed -$335K 402
2018
Q3
$335K Buy
948
+222
+31% +$76.4K 0.07% 279
2018
Q2
$211K Buy
+726
New +$204K 0.05% 363
2016
Q2
Sell
-1,822
Closed -$474K 204
2016
Q1
$474K Buy
1,822
+45
+3% +$11.9K 0.2% 123
2015
Q4
$544K Buy
+1,777
New +$511K 0.22% 114

Other funds holding BIIB

Dynamic Advisor Solutions's BIIB Position: Q3 2024 in Review

Dynamic Advisor Solutions sold out of Biogen (BIIB) in Q3 2024, closing a stake of 877 shares — an estimated $203K sold.

Dynamic Advisor Solutions first reported a position in BIIB in Q4 2015 and held it in 10 quarters. The position peaked at $1.29M in Q2 2023. 916 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Dynamic Advisor Solutions reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • Dynamic Advisor Solutions sold 877 Biogen shares in Q3 2024, an estimated $203K.
  • Dynamic Advisor Solutions first reported a position in Biogen in Q4 2015 and held it in 10 quarters.
  • Dynamic Advisor Solutions's Biogen position peaked at $1.29M in Q2 2023.
  • 916 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Dynamic Advisor Solutions's 13F filing for Q3 2024, filed 7 Oct 2024.